<

SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis

Transparency directive : regulatory news

18/03/2023 15:00



Other stories

18/05/2024 15:26
18/05/2024 20:56
18/05/2024 17:40
18/05/2024 20:44
18/05/2024 18:32
18/05/2024 21:33
18/05/2024 18:50
18/05/2024 20:16
18/05/2024 18:07
18/05/2024 08:53
18/05/2024 20:54
18/05/2024 17:00
18/05/2024 18:49
18/05/2024 19:20
18/05/2024 18:43
17/05/2024 20:25
18/05/2024 13:51
18/05/2024 19:25
18/05/2024 12:41
18/05/2024 14:00
17/05/2024 20:08
16/05/2024 23:30
18/05/2024 20:00
18/05/2024 21:00
18/05/2024 16:04
18/05/2024 15:50
16/05/2024 21:19
18/05/2024 18:39
18/05/2024 20:28
18/05/2024 21:30
17/05/2024 07:36
17/05/2024 01:00
18/05/2024 16:00
18/05/2024 19:33
18/05/2024 20:16
18/05/2024 11:17
18/05/2024 15:52
18/05/2024 08:18